-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IPbTkEDvU+XlfwCEyvzKbb6ap0fdrb6RVTxcx+n6f1B+eHXKFoZlXfDwS05/8PLT j0I5JGYNnuSDoOd4akkIqw== 0000950133-01-000516.txt : 20010214 0000950133-01-000516.hdr.sgml : 20010214 ACCESSION NUMBER: 0000950133-01-000516 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010213 GROUP MEMBERS: ARMONK PARTNERS GROUP MEMBERS: CHARLES M. FLEISCHMAN GROUP MEMBERS: EVAN JONES SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DIGENE CORP CENTRAL INDEX KEY: 0001011582 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 521536128 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-46641 FILM NUMBER: 1535844 BUSINESS ADDRESS: STREET 1: 1201 CLOPPER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 3019447000 MAIL ADDRESS: STREET 1: 2301 B BROADBIRCH DRIVE STREET 2: 1201 CLOPPER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20904 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ARMONK PARTNERS CENTRAL INDEX KEY: 0001020799 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: CT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 9000 VIRGINIA MANOR RD STREET 2: STE 206 CITY: BELTSVILLE STATE: MD ZIP: 20705 BUSINESS PHONE: 3014706502 MAIL ADDRESS: STREET 1: 9000 VIRGINIA MANOR RD STREET 2: STE 206 CITY: BELTSVILLE STATE: MD ZIP: 20705 SC 13G/A 1 w45417sc13ga.txt AMENDMENT NO. 2 TO SCHEDULE 13G 1 Page 1 of 7 Pages Securities and Exchange Commission Washington, D.C. 20549 SCHEDULE 13G AMENDMENT NO. 2 Under the Securities Exchange Act of 1934 Digene Corporation --------------------------- (Name of Issuer) Common Stock --------------------- (Title of Class of Securities) 253752 10 9 -------------------- (CUSIP Number) As of February 12, 2001 -------------------------------- (Date of Event which Requires Filing of this Statement) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that Section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 CUSIP No. 253752 10 9 Page 2 of 7 Pages - -------------------------------------------------------------------------------- 1) Names of Reporting Persons; I.R.S. Identification Nos. (entities only) Armonk Partners I.R.S # 06 1305405 - -------------------------------------------------------------------------------- 2) Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Citizenship or Place of Organization Connecticut - -------------------------------------------------------------------------------- Number of 5) Sole Voting Power 4,701,715 Shares Beneficially --------------------------------------------------- Owned by Each 6) Shared Voting Power 0 Reporting Person --------------------------------------------------- With 7) Sole Dispositive Power 4,701,715 --------------------------------------------------- 8) Shared Dispositive Power 0 - -------------------------------------------------------------------------------- 9) Aggregate Amount Beneficially Owned by Each Reporting Person 4,701,715 - -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) - -------------------------------------------------------------------------------- 11) Percent of Class Represented by Amount in Row (9) 28.2% - -------------------------------------------------------------------------------- 12) Type of Reporting Persons (See Instructions) PN - -------------------------------------------------------------------------------- 3 CUSIP No. 253752 10 9 Page 3 of 7 Pages - -------------------------------------------------------------------------------- 1) Names of Reporting Persons; I.R.S. Identification Nos. (entities only) Evan Jones SS # - -------------------------------------------------------------------------------- 2) Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Citizenship or Place of Organization United States - -------------------------------------------------------------------------------- Number of 5) Sole Voting Power 361,011 Shares Beneficially --------------------------------------------------- Owned by Each 6) Shared Voting Power 4,701,715 Reporting Person --------------------------------------------------- With 7) Sole Dispositive Power 361,011 --------------------------------------------------- 8) Shared Dispositive Power 4,701,715 - -------------------------------------------------------------------------------- 9) Aggregate Amount Beneficially Owned by Each Reporting Person 5,062,726 - -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] - -------------------------------------------------------------------------------- 11) Percent of Class Represented by Amount in Row (9) 29.7% - -------------------------------------------------------------------------------- 12) Type of Reporting Persons (See Instructions) IN - -------------------------------------------------------------------------------- 4 CUSIP No. 253752 10 9 Page 4 of 7 Pages - -------------------------------------------------------------------------------- 1) Names of Reporting Persons; I.R.S. Identification Nos. (entities only) Charles M. Fleischman SS # - -------------------------------------------------------------------------------- 2) Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Citizenship or Place of Organization United States - -------------------------------------------------------------------------------- Number of 5) Sole Voting Power 359,852 Shares Beneficially --------------------------------------------------- Owned by Each 6) Shared Voting Power 4,701,715 Reporting Person --------------------------------------------------- With 7) Sole Dispositive Power 359,852 --------------------------------------------------- 8) Shared Dispositive Power 4,701,715 - -------------------------------------------------------------------------------- 9) Aggregate Amount Beneficially Owned by Each Reporting Person 5,061,567 - -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] - -------------------------------------------------------------------------------- 11) Percent of Class Represented by Amount in Row (9) 29.7% - -------------------------------------------------------------------------------- 12) Type of Reporting Persons (See Instructions) IN - -------------------------------------------------------------------------------- 5 CUSIP No. 253752 10 9 Page 5 of 7 Pages ITEM 1. (a) Name of issuer: Digene Corporation (b) Address of issuer's principal executive offices: 1201 Clopper Road Gaithersburg, Maryland 20878 ITEM 2. (a) Name of Person Filing: This Schedule 13G, Amendment No. 2 is being filed by (i) Armonk Partners, (ii) Evan Jones, a managing partner of Armonk Partners and (iii) Charles M. Fleischman, a managing partner of Armonk Partners. (b) Address of Principal Business Address: The principal business address for Armonk Partners, Evan Jones and Charles M. Fleischman is 1201 Clopper Road, Gaithersburg, Maryland, 20878. (c) Citizenship: Armonk Partners is a Connecticut partnership. Messrs. Jones and Fleischman are citizens of the United States. (d) Title of Class of Securities: Common Stock (e) CUSIP Number 253752 10 9 6 CUSIP No. 253752 10 9 Page 6 of 7 Pages ITEM 4. OWNERSHIP. BY ARMONK PARTNERS:
(a) Amount beneficially owned: 4,701,715 * (b) Percent of class: 28.2% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 4,701,715 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 4,701,715 (iv) Shared power to dispose or to direct the disposition of: 0
BY EVAN JONES:
(a) Amount beneficially owned: 5,062,726 ** (b) Percent of class: 29.7% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 361,011 (ii) Shared power to vote or to direct the vote: 4,701,715 * (iii) Sole power to dispose or to direct the disposition of: 361,011 (iv) Shared power to dispose or to direct the disposition of: 4,701,715 *
BY CHARLES M. FLEISCHMAN:
(a) Amount beneficially owned: 5,061,567 *** (b) Percent of class: 29.7% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 359,852 (ii) Shared power to vote or to direct the vote: 4,701,715 * (iii) Sole power to dispose or to direct the disposition of: 359,852 (iv) Shared power to dispose or to direct the disposition of: 4,701,715 *
- ----------- * As the managing partners of Armonk Partners, Evan Jones and Charles M. Fleischman share voting and investment power over these shares. ** Consists of: (1) 10,621 shares owned directly by Mr. Jones; (2) 4,701,715 shares owned by Armonk Partners as to which Mr. Jones shares voting and investment power as a managing partner; (3) 14,676 shares owned by Mr. Jones' wife as to which he disclaims beneficial ownership; and (4) 335,714 shares issuable upon the exercise of stock options. *** Consists of: (1) 7,466 shares owned directly by Mr. Fleischman; (2) 4,701,715 shares owned by Armonk Partners as to which Mr. Fleischman shares voting and investment power as a managing partner; (3) 16,672 shares held in trust for Mr. Fleischman's minor children as to which Mr. Fleischman disclaims beneficial ownership; and (4) 335,714 shares issuable upon the exercise of stock options. 7 CUSIP No. 253752 10 9 Page 7 of 7 Pages SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement on Schedule 13G, Amendment Number 2 is true, complete and correct as of the date hereof. Dated: February 12, 2001 ARMONK PARTNERS /s/ Evan Jones -------------------------------------------- By: Evan Jones Title: Managing Partner /s/ Charles M. Fleischman -------------------------------------------- By: Charles M. Fleischman Title: Managing Partner /s/ Evan Jones -------------------------------------------- Evan Jones /s/ Charles M. Fleischman -------------------------------------------- Charles M. Fleischman 8 JOINT FILING AGREEMENT The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, Amendment No. 2 is filed on behalf of each of the undersigned and that all subsequent amendments to this statement shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it or him contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it or he knows or has reason to believe that such information is inaccurate. This Agreement may be executed counterparts and each of such counterparts taken together shall constitute one and the same instrument. Dated: February 12, 2001 ARMONK PARTNERS /s/ Evan Jones -------------------------------------------- By: Evan Jones Title: Managing Partner /s/ Charles M. Fleischman -------------------------------------------- By: Charles M. Fleischman Title: Managing Partner /s/ Evan Jones -------------------------------------------- Evan Jones /s/ Charles M. Fleischman -------------------------------------------- Charles M. Fleischman -----END PRIVACY-ENHANCED MESSAGE-----